Nicolas Gaboriaud‐Kolar

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases

Vassilios Myrianthopoulos, Marina Kritsanida, Nicolas Gaboriaud‐Kolar et al. · ACS Medicinal Chemistry Letters · 2012 · 68 citations · Full text

Crystal Structure, Drug Target, Molecular Biology +20

6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts

Aimilia D. Sklirou, Nicolas Gaboriaud‐Kolar, Issidora S. Papassideri et al. · Scientific Reports · 2017 · 65 citations · Full text

Chemoprevention Strategy, Lipid Peroxidation, Cell Death +20

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity

Émilie Durieu, Eric Prina, L Olivier et al. · Antimicrobial Agents and Chemotherapy · 2016 · 57 citations · Full text

Drug Target, Parasite Resistance, Antiparasitic Agent +19

Oxidative Burst Inhibitory and Cytotoxic Indoloquinazoline and Furoquinoline Alkaloids from <i>Oricia suaveolens</i>

Jean Duplex Wansi, M. Ahmed Mesaik, David Dako Chiozem et al. · Journal of Natural Products · 2008 · 50 citations

Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis

Vassilios Myrianthopoulos, Nicolas Gaboriaud‐Kolar, C. Tallant et al. · Journal of Medicinal Chemistry · 2016 · 49 citations · Full text